Notify me when ExodusPoint Capital Management, LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ALTS | ALT5 Sigma Corp | Common Stock, $0.001 par value per share | 4.8% | $36,487,241 | 5,856,700 | ExodusPoint Capital Management, LP | 11 Aug 2025 | ||
| KROS | Keros Therapeutics, Inc. | Common Stock, $0.0001 par value per share | 0.04% | $260,520 | -$36,943,510 | 13,360 | -99% | ExodusPoint Capital Management, LP | 31 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|